Andrew Hamer

Direttore Tecnico/Scientifico/R&S presso CARDIOL THERAPEUTICS INC.

Patrimonio netto: 440 459 $ in data 30/04/2024

62 anni

Health Technology

Consumer Services

Posizioni attive di Andrew Hamer

Società	Posizione	Inizio	Fine
CARDIOL THERAPEUTICS INC.	Direttore Tecnico/Scientifico/R&S	29/03/2021	-

Società	Posizione	Inizio	Fine
AMGEN INC.	Corporate Officer/Principal	01/01/2018	01/03/2021
CAPRICOR THERAPEUTICS, INC.	Direttore Tecnico/Scientifico/R&S	22/11/2013	30/07/2015
Capricor, Inc. Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013.	Direttore Tecnico/Scientifico/R&S	01/11/2013	-

University of Otago

Undergraduate Degree

Distribuzione geografica

Posizioni

Chief Tech/Sci/R&D Officer	3
Undergraduate Degree	1
Corporate Officer/Principal	1

Settori

Health Technology	5
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	1
Capricor, Inc. Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013.	Health Technology

Aziende private

Health Technology